Back to results
US 2023/0105440 A1Published application
Anti-thrombogenic coating
AssigneeMedtronic, Inc.
InventorsValentino J. Tramontano, Sean A. McDermott
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeMedtronic, Inc.
InventorsValentino J. Tramontano, Sean A. McDermott
Estimating the term…
An example medical device includes a vascular device, such as a catheter, and an anti-thrombogenic coating on a surface of the vascular device, such as a surface likely to contact blood. The anti-thrombogenic coating includes one or more peptides configured to interact with fibrinogen in the blood, such as a first type of peptides configured to bind to fibrinogen a second type of peptides configured to inhibit conversion of fibrinogen to fibrin. The anti-thrombogenic coating also includes a polymer, such as a hydrocolloid polymer, a tunable polyethylene glycol (PEG), or other controlled release polymer configured to control release of the one or more peptides and maintain a concentration of the peptides at the surface of the anti-thrombogenic coating above a minimum inhibitory concentration, thereby inhibiting thrombin formation on the intravascular medical device.
A medical device comprising:
A hemodialysis medical assembly comprising:
A method comprising:
Dependencies are inferred from the claim text.